Please login to the form below

Not currently logged in
Email:
Password:

cervical cancer

This page shows the latest cervical cancer news and features for those working in and with pharma, biotech and healthcare.

Keytruda doubles five-year survival rate in NSCLC

Keytruda doubles five-year survival rate in NSCLC

Since then, the immunotherapy has added an array of indications to its arsenal, including approvals for the treatment of head and neck squamous cell carcinoma, classical Hodgkin lymphoma (cHL), cervical cancer, ... AstraZeneca’s Imfinzi (durvalumab)

Latest news

  • AZ’s comeback drug cediranib stumbles in phase 3 trial AZ’s comeback drug cediranib stumbles in phase 3 trial

    and cervical cancer indications, particularly the ICON6 study sponsored by Cancer Research UK. ... That results led to speculation that the combination could become a chemo-free option for relapsed ovarian cancer patients.

  • Merck CFO: we’re not only about Keytruda Merck CFO: we’re not only about Keytruda

    He said the performance of other cancer drugs like Lenvima (lenvatinib) and Lynparza (olaparib), revenue from which doubled in the quarter – as well as the vaccine portfolio headed by cervical cancer ... Merck is also conducting a trial of Keytruda

  • Cancer Research UK among partners in new international research alliance Cancer Research UK among partners in new international research alliance

    CRUK acknowledged that although existing screening programmes for some cancers, including bowel, breast and cervical cancer, have seen great improvement, there are still many cancer types which have no screening methods, ... Benefits for patients will

  • GSK eyes follow-up HPV vaccine GSK eyes follow-up HPV vaccine

    Innovax has already developed a cervical cancer vaccine, Cecolin, which is HPV 16 &18 bivalent – these two HPV types are known to cause at least 70% of cervical cancers. ... Under the agreement, Innovax said it and GSK “will continuously support the

  • Sanofi/Regeneron’s IO latecomer Libtayo approved in Europe Sanofi/Regeneron’s IO latecomer Libtayo approved in Europe

    Cases of the skin cancer are increasing in certain European countries, there is little on the market for those suffering with advanced stages of the disease. ... cell carcinoma and cervical cancer.

More from news
Approximately 9 fully matching, plus 147 partially matching documents found.

Latest Intelligence

  • Surviving cancer: a new era for patients Surviving cancer: a new era for patients

    This treatment quickly became the ‘gold standard’ for women with metastatic breast cancer. ... a terminal disease, and more towards helping cancer patients manage their condition effectively.

  • 2019: CRISPR and therapeutic gene editing comes of age 2019: CRISPR and therapeutic gene editing comes of age

    hope was that - without the brake of PD-1 – the edited cells would attack and defeat the cancer. ... The approach is however also set to be tested as an in vivo therapy for cervical cancer caused by human papillomavirus (HPV) by researchers in China,

  • AI’s potential in the pharma life cycle AI’s potential in the pharma life cycle

    Proactive intervention. Already AI is being used to identify women whose Twitter posts indicate they may have increased risk of developing two relatively rare diseases: ovarian cancer and cervical cancer.

  • Immunisation politicised Immunisation politicised

    human papilloma virus (HPV), including strains that lead to cervical cancer. ... Practitioners were concerned that a hasty introduction of the vaccine would lead to lower participation rates in cervical cancer screening programmes using the pap smear test

  • Pharma deals in August 2015 Pharma deals in August 2015

    Immuno-oncology combinations in lung cancer. Not disclosed. Peregrine Pharmaceuticals. Combination clinical trials. ... Acquisition ‐ company. 847. Inovio. AZ/Medimmune. INO‐3112 vaccine in P1/2 for cervical and head &neck cancer.

More from intelligence
Approximately 0 fully matching, plus 8 partially matching documents found.

Latest appointments

  • Merck appoints new senior vice president Merck appoints new senior vice president

    Radvanyi will focus on leading the discovery of oncology therapies that leverage the natural ability of the body's immune system to fight cancer, as well as identifying biomarkers with the ... indications including lung, cervical and breast cancer.

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

  • The impact of COVID-19 on cancer care

    Cancer screening. The NHS offers bowel, breast and cervical cancer screening programmes to identify individuals at high risk of these cancers and to enable early diagnosis and treatment for those affected. ... that the diagnosis and management of

  • A new vision for tackling key illnesses

    The NHS will also implement HPV primary screening for cervical cancer across England by 2020. ... Cancer Alliances will also work with Integrated Care Systems (ICSs) to aid swift access to a consultant’s opinion.

  • Is our health at risk by delaying Dr appointments? Is our health at risk by delaying Dr appointments?

    2. It is understood that another contributory factor for the development of cervical cancer is smoking cigarettes. ... infections. Therefore, cutting down on smoking could help to reduce the risk of developing cervical cancer.

  • Parachuting Behind Enemy Lines: OncoSec’s Attack on Visceral Tumors via Its New Visceral Lesion Applicator (VLA)

    OncoSec’s therapeutic platform currently has 2 registration-directed clinical trials in advanced melanoma and cervical cancer, and has demonstrated efficacy in other cutaneous tumor indications, including head and neck squamous ... 2018; 15(10):599-616.

  • A walk in the park!

    The emotive. team help raise awareness for Jo’s Cervical Cancer Trust. ... You can find out more about Jo’s Cervical Cancer Trust and the work that they do at their website, including the Steps for Jo’s event and the upcoming Cervical

More from PMHub
Approximately 1 fully matching, plus 6 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Jet Off with Maloff Protect

Latest intelligence

Not waving but drowning. Reflections on data curation in the age of information overload
...
digital healthcare chronic disease
Digital healthcare may revolutionise management of chronic diseases, but who is going to pay for it?
Providers are looking at digital solutions to transform this area of healthcare...
Live webinar:
The power of a good story: Turn your insights into effective storytelling with data visualisation...

Infographics